Home Coronavirus Study: COVID Could Be Treated for Less than $1 a Day

Study: COVID Could Be Treated for Less than $1 a Day

#COVID #treatment #ivermectin


A double-blind study of an antiparasitic drug that’s been in the news a lot lately not only shows that the drug can reduce the duration and infectiousness of COVID-19, but can do all that on less than $1 a day.

That drug is ivermectin, and Professor Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, says his studies, recently published on RXiv, show it is a cost-effective treatment that can help shorten the infection period. Dr. Schwartz studied 89 volunteers diagnosed with the virus, 50% received ivermectin; the other 50%, a placebo.

Nearly 72% of volunteers treated with ivermectin tested negative for the virus by Day 6,” The Jerusalem Post reported. “In contrast, only 50% of those who received the placebo tested negative.” And, besides feeling better quicker, fewer ivermectin patients also were found to be infectious: 13%, compared to 50% of the placebo group.

The findings also showed that “there is almost a 100% chance that a person will be noninfectious in four to 6 days,” Dr. Schwartz said.

Ivermectin is an inexpensive drug that was approved by the US FDA in Y 1987 for treatment of a parasitic roundworm.

The loudest opposition to ivermectin has come from Merck Co (NYSE:MRK), which manufactured the drug in the 1980s.

In a public statement about ivermectin on its website in February, it said: “Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to date, our analysis has identified no scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies; no meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and a concerning lack of safety data in the majority of studies.”

Merck has not launched any studies of its own on ivermectin.

Have a healthy, prosperous day, Keep the Faith!

Previous articleDrink More Water!
Next articleThere is Nothing Positive about Being Obese
Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.